<img alt="" height="1" width="1" />
Bristol, Astra report diabetes pill cancer rates
SAN DIEGO (Reuters) - A new type of diabetes pill being developed by Bristol-Myers Squibb and AstraZeneca was effective in a two-year study, but the companies said more bladder and breast cancers have been seen in patients treated with ...
Investigational Compound Dapagliflozin Sustained Glycemic Control and Weight ...MarketWatch (press release)
Bristol-Myers, AstraZeneca Diabetes Compound Onglyza Clears Phase 3b TrialRTT News
Bristol-Myers diabetes drug draws scrutiny after AvandiaBangor Daily News
Newswise (press release) -Drug Store News
all 32 news articles &raquo;